HK StockDetailed Quotes

Provided by TTMF Limited

BIOKINUnlisted

Volume:- -

Turnover:- -

Market Cap:- -

PE:- -

High:- -

Open:- -

Low:- -

Close:- -

52wk High:- -

52wk Low:- -

Shares:421.51M

HK Float Shares:421.51M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:-14.94%

ROA:-5.41%

PB:0.00

PE(LYR):- -

PS:0.00

Offering

Nov 07

Closed

Nov 12 09:30

IPO Result

Nov 13

Grey Mkt.

Dec 31 16:15 - 18:30

Listing

Nov 17

Overview Company News Filings

Company Profile

Company Name:

BIOKIN

Exchange:

SEHK

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.baili-pharm.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

The company is a biomedical enterprise focusing on the frontier of global CNI Biomedicine Index, based on solving unmet clinical needs, with a full range of drug research and development capabilities, including small molecule chemicals, large molecule biopharmaceuticals and ADC drugs, and has integrated advantages from intermediates, APIs to formulations, and commercial operation capabilities covering the entire “R&D, production and marketing” life cycle. The company has two major business Sector, namely the innovative biopharmaceuticals business and the chemical preparations and proprietary Chinese medicine business Sector. The company's main products: propofol emulsion injection, propofol medium/long chain fat emulsion injection, heptafluorane for inhalation, structural fat emulsion injection (C6-24), astragalus granules, guanfacine hydrochloride sustained-release tablets, glucose electrolyte effervescent tablets.

Directors

Name

Position

ZHU Yi

Chairman of the Board,Director,Chief Science Officer,Core Technical Personnel,Chairman of the Strategic and Development Committee,Member of the Strategic and Development Committee

LI Ming Yuan

Independent Director,Member of the Strategic and Development Committee,Chairman of the Nomination Committee,Member of the Nomination Committee,Member of the Audit Committee

XIAO Geng

Independent Director,Member of the Strategic and Development Committee,Chairman of the Remuneration and Assessment Committee,Member of the Remuneration and Assessment Committee,Member of the Audit Committee

DAI Ze Wei

Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Chairman of the Audit Committee,Member of the Audit Committee

ZHUO Shi

Director,Core Technical Personnel

David Guowei Wang

Director

ZHU Hai

Director,Core Technical Personnel

WAN Wei Li

Director,Core Technical Personnel

ZHANG Su Ya

Director,Other Senior Executives,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee

CHEN Xue Yu

Securities Affairs Representative

WANG Cheng

Corporate Secretary,Other Senior Executives

JAHAN SALAR KHALILI

Core Technical Personnel

Shareholders

Name

Position

ZHU Yi

General Manager

ZHANG Su Ya

Deputy General Manager,CFO,Acting Board Secretary

WANG Xiao Xiao

Vice General Manager

HE Yong

Vice General Manager